The emerging role of monitoring serum HER-2/neu oncoprotein levels in women with metastatic breast cancer

被引:12
作者
Carney, WP [1 ]
机构
[1] Oncogene Sci, Cambridge, MA USA
关键词
D O I
10.1309/TY6M-DWB0-G2BU-6D5F
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The HER-2/neu oncogene encodes a transmembrane growth factor receptor protein that is overexpressed in a variety of cancer cells. The HER-2/neu oncoprotein has become a major target for the development of new cancer therapies. Studies show that monitoring serum HER-2/neu levels during metastatic breast cancer can provide a real-time assessment of a woman's HER-2/neu status and can provide important information for making therapeutic decisions.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 30 条
[1]   DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR [J].
ANDERSEN, TI ;
PAUS, E ;
NESLAND, JM ;
MCKENZIE, SJ ;
BORRESEN, AL .
ACTA ONCOLOGICA, 1995, 34 (04) :499-504
[2]  
BRANDTRAUF PW, 1995, CRITICAL REV ONCOGEN, P313
[3]  
CARNEY W P, 1991, Journal of Tumor Marker Oncology, V6, P53
[4]  
Cook GB, 2001, ANTICANCER RES, V21, P1465
[5]  
COUSSEN SL, 1985, SCIENCE, P1132
[6]  
DA NO, 1995, ONCOLOGY, V52, P392
[7]   Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer [J].
Esteva, FJ ;
Valero, V ;
Booser, D ;
Guerra, LT ;
Murray, JL ;
Pusztai, L ;
Cristofanilli, M ;
Arun, B ;
Esmaeli, B ;
Fritsche, HA ;
Sneige, N ;
Smith, TL ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1800-1808
[8]  
HAYES D F, 1989, Breast Cancer Research and Treatment, V14, P135
[9]  
KAPTAIN S, 2001, DIAGNOSTIC MOL PATHO, P139
[10]  
Krainer M, 1997, ONCOLOGY, V54, P475